These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3100314)

  • 1. Correlations between in vitro dissolution, in vivo bioavailability and hypoglycaemic effect of oral glibenclamide.
    Chalk JB; Patterson M; Smith MT; Eadie MJ
    Eur J Clin Pharmacol; 1986; 31(2):177-82. PubMed ID: 3100314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo evaluation of glibenclamide in solid dispersion systems.
    Tashtoush BM; Al-Qashi ZS; Najib NM
    Drug Dev Ind Pharm; 2004 Jul; 30(6):601-7. PubMed ID: 15285333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability and pharmacodynamics of a sustained-release glibenclamide product (Deroctyl) in comparison to a standard tablet formulation (Euglucon, Daonil).
    Ayanoglu G; Witte PU; Badian M
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):479-82. PubMed ID: 6414955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute bioavailability and bioequivalence of glibenclamide (Semi-Euglucon N).
    Neugebauer G; Betzien G; Hrstka V; Kaufmann B; von Möllendorff E; Abshagen U
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):453-60. PubMed ID: 3932228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative bioavailability of furosemide from solution and 40 mg tablets with different dissolution characteristics following oral administration in normal men.
    Waller ES; Crismon ML; Smith RV; Bauza MT; Doluisio JT
    Biopharm Drug Dispos; 1988; 9(2):211-8. PubMed ID: 3370308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased dissolution rate and oral bioavailability of hydrophobic drug glyburide tablets produced using supercritical CO₂ silica dispersion technology.
    Guan J; Han J; Zhang D; Chu C; Liu H; Sun J; He Z; Zhang T
    Eur J Pharm Biopharm; 2014 Apr; 86(3):376-82. PubMed ID: 24184803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the pharmacokinetics and pharmacodynamics of two commercial products containing glibenclamide.
    el-Sayed YM; Suleiman MS; Hasan MM; Abdel-Hamid ME; Najib NM; Sallam ES; Shubair MS
    Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):551-7. PubMed ID: 2515159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of tolazamide from tablets: comparison of in vitro and in vivo results.
    Welling PG; Patel RB; Patel UR; Gillespie WR; Craig WA; Albert KS
    J Pharm Sci; 1982 Nov; 71(11):1259-63. PubMed ID: 7175719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo/in vitro correlations for four differently dissolving ketorolac tablets.
    Gordon MS; Chowhan Z
    Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro in-vivo correlation models for glibenclamide after administration of metformin/glibenclamide tablets to healthy human volunteers.
    Balan G; Timmins P; Greene DS; Marathe PH
    J Pharm Pharmacol; 2000 Jul; 52(7):831-8. PubMed ID: 10933133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmaceutical and biological availability of commercial preparations of furosemide.
    Stüber W; Mutschler E; Steinbach D
    Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
    Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
    Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The paradoxical effect of cimetidine and ranitidine on glibenclamide pharmacokinetics and pharmacodynamics.
    Kubacka RT; Antal EJ; Juhl RP
    Br J Clin Pharmacol; 1987 Jun; 23(6):743-51. PubMed ID: 3111514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.
    Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C
    Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between in vitro dissolution rate and bioavailability of alaproclate tablets.
    Graffner C; Nicklasson M; Lindgren JE
    J Pharmacokinet Biopharm; 1984 Aug; 12(4):367-80. PubMed ID: 6527230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative bioavailability of three commercial acetaminophen tablets.
    Hekimoğlu S; Ayanoğlu-Dülger G; Hincal AA
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):93-6. PubMed ID: 3557735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of pharmacokinetics and pharmacodynamics.
    Rydberg T; Jönsson A; Karlsson MO; Melander A
    Br J Clin Pharmacol; 1997 Apr; 43(4):373-81. PubMed ID: 9146849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing dissolution, serum concentrations and hypoglycemic effect of glibenclamide using solvent deposition technique.
    Dastmalchi S; Garjani A; Maleki N; Sheikhee G; Baghchevan V; Jafari-Azad P; Valizadeh H; Barzegar-Jalali M
    J Pharm Pharm Sci; 2005 Aug; 8(2):175-81. PubMed ID: 16124928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.